Cargando…

CircRNAs as potent biomarkers in ovarian cancer: a systematic scoping review

More powerful prognostic and diagnostic tools are urgently needed for identifying and treating ovarian cancer (OC), which is the most fatal malignancy in women in developed countries. Circular RNAs (circRNAs) are conservative and stable looped molecules that can regulate gene expression by competing...

Descripción completa

Detalles Bibliográficos
Autores principales: Foruzandeh, Zahra, Zeinali-Sehrig, Fatemeh, Nejati, Kazem, Rahmanpour, Dara, Pashazadeh, Fariba, Seif, Farhad, Alivand, Mohammad Reza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461915/
https://www.ncbi.nlm.nih.gov/pubmed/34556024
http://dx.doi.org/10.1186/s11658-021-00284-7
_version_ 1784572088134139904
author Foruzandeh, Zahra
Zeinali-Sehrig, Fatemeh
Nejati, Kazem
Rahmanpour, Dara
Pashazadeh, Fariba
Seif, Farhad
Alivand, Mohammad Reza
author_facet Foruzandeh, Zahra
Zeinali-Sehrig, Fatemeh
Nejati, Kazem
Rahmanpour, Dara
Pashazadeh, Fariba
Seif, Farhad
Alivand, Mohammad Reza
author_sort Foruzandeh, Zahra
collection PubMed
description More powerful prognostic and diagnostic tools are urgently needed for identifying and treating ovarian cancer (OC), which is the most fatal malignancy in women in developed countries. Circular RNAs (circRNAs) are conservative and stable looped molecules that can regulate gene expression by competing with other endogenous microRNA sponges. This discovery provided new insight into novel methods for regulating genes that are involved in many disorders and cancers. This review focuses on the dysregulated expression of circRNAs as well as their diagnostic and prognostic values in OC. We found that studies have identified twenty-one downregulated circRNAs and fifty-seven upregulated ones. The results of these studies confirm that circRNAs might be potent biomarkers with diagnostic, prognostic and therapeutic target value for OC. We also consider the connection between circRNAs and OC cell proliferation, apoptosis, metastasis, and chemotherapy resistance and sensitivity. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s11658-021-00284-7.
format Online
Article
Text
id pubmed-8461915
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-84619152021-09-24 CircRNAs as potent biomarkers in ovarian cancer: a systematic scoping review Foruzandeh, Zahra Zeinali-Sehrig, Fatemeh Nejati, Kazem Rahmanpour, Dara Pashazadeh, Fariba Seif, Farhad Alivand, Mohammad Reza Cell Mol Biol Lett Review Letter More powerful prognostic and diagnostic tools are urgently needed for identifying and treating ovarian cancer (OC), which is the most fatal malignancy in women in developed countries. Circular RNAs (circRNAs) are conservative and stable looped molecules that can regulate gene expression by competing with other endogenous microRNA sponges. This discovery provided new insight into novel methods for regulating genes that are involved in many disorders and cancers. This review focuses on the dysregulated expression of circRNAs as well as their diagnostic and prognostic values in OC. We found that studies have identified twenty-one downregulated circRNAs and fifty-seven upregulated ones. The results of these studies confirm that circRNAs might be potent biomarkers with diagnostic, prognostic and therapeutic target value for OC. We also consider the connection between circRNAs and OC cell proliferation, apoptosis, metastasis, and chemotherapy resistance and sensitivity. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s11658-021-00284-7. BioMed Central 2021-09-23 /pmc/articles/PMC8461915/ /pubmed/34556024 http://dx.doi.org/10.1186/s11658-021-00284-7 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Review Letter
Foruzandeh, Zahra
Zeinali-Sehrig, Fatemeh
Nejati, Kazem
Rahmanpour, Dara
Pashazadeh, Fariba
Seif, Farhad
Alivand, Mohammad Reza
CircRNAs as potent biomarkers in ovarian cancer: a systematic scoping review
title CircRNAs as potent biomarkers in ovarian cancer: a systematic scoping review
title_full CircRNAs as potent biomarkers in ovarian cancer: a systematic scoping review
title_fullStr CircRNAs as potent biomarkers in ovarian cancer: a systematic scoping review
title_full_unstemmed CircRNAs as potent biomarkers in ovarian cancer: a systematic scoping review
title_short CircRNAs as potent biomarkers in ovarian cancer: a systematic scoping review
title_sort circrnas as potent biomarkers in ovarian cancer: a systematic scoping review
topic Review Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461915/
https://www.ncbi.nlm.nih.gov/pubmed/34556024
http://dx.doi.org/10.1186/s11658-021-00284-7
work_keys_str_mv AT foruzandehzahra circrnasaspotentbiomarkersinovariancancerasystematicscopingreview
AT zeinalisehrigfatemeh circrnasaspotentbiomarkersinovariancancerasystematicscopingreview
AT nejatikazem circrnasaspotentbiomarkersinovariancancerasystematicscopingreview
AT rahmanpourdara circrnasaspotentbiomarkersinovariancancerasystematicscopingreview
AT pashazadehfariba circrnasaspotentbiomarkersinovariancancerasystematicscopingreview
AT seiffarhad circrnasaspotentbiomarkersinovariancancerasystematicscopingreview
AT alivandmohammadreza circrnasaspotentbiomarkersinovariancancerasystematicscopingreview